← Back to Clinical Trials
Recruiting NCT06185920

PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Severe Infection
Sponsor Hospices Civils de Lyon
Study Type OBSERVATIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2023-02-01
Completion 2033-02-01
Interventions
Description of severe infection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Eligibility Criteria

Inclusion Criteria: * Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033 * PHAGEinLYON Clinic cohort study information notice provided to the patient Exclusion Criteria: * Opposition of trial participant

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE SEVERE INFECTION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}